top of page

Treating brain disease from within

Brain disorders, meet RNA therapeutics. With a new approach, neurological disorders can be treated.

CereCura Nanotherapeutics is a preclinical biotechnology company developing a disease-agnostic approach using lipid nanoparticles and RNA  to overcome barriers to CNS treatment.

An innovative therapeutic approach

Untitled (21)_edited.png

Lipid nanoparticles

Validated nucleic acid delivery vector


CNS delivery

Unique CNS drug delivery strategy

Untitled (20)_edited_edited.png
Untitled (20)_edited_edited.png

RNA therapeutics

Harnessing the power of genetic drugs

Partner with us

Join us in our mission to pioneer a novel class of genetic drugs for untreated brain disorders
bottom of page